STAT says new documents have raised further questions about Medicare’s AI prior-authorisation experiment. The article points to ongoing scrutiny of how artificial intelligence is being used in healthcare authorisation processes.
This matters for healthcare executives and insurers as it signals persistent regulatory and operational uncertainty. The results may affect future adoption of AI in clinical settings and how authorisation decisions are made.
